SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Tagore who wrote (766)1/26/1999 10:45:00 AM
From: John Lacelle  Respond to of 1255
 
Tagore,

Thanks for the good news. I would rate
old CORX a buy at this point. Perhaps
I can pick up a bunch of shares...

-John



To: Tagore who wrote (766)1/28/1999 7:18:00 AM
From: a. paisley  Read Replies (1) | Respond to of 1255
 
if public knew they got 10mill milestone payment it would show up on next qtr results how many shares did they get or just royalty from drug patents on 10 mill stock should be 3 or 4 dollar if results are good its a buyout this is as good as gene mapping and there has been huge cash infusions to those companies


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News